These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4174291)

  • 1. A new vitamin B12 binding protein in serum causing excessively high serum vitamin B12 values.
    Schwartz M; Bastrup-Madsen P
    Scand J Haematol; 1968; 5(1):35-40. PubMed ID: 4174291
    [No Abstract]   [Full Text] [Related]  

  • 2. Turnover of 57Co-labelled vitamin B12-transcobalamin II and autologous 131-I-labelled IgG in a patient with antibody to transcobalamin II.
    Hom BL; Olesen H; Schwartz M
    Scand J Haematol; 1968; 5(2):107-15. PubMed ID: 4175218
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the abnormal high binding capacity of blood for vitamin B 12 in chronic myeloid leukemia.
    Fischer E
    Clin Chim Acta; 1972 Feb; 36(2):409-18. PubMed ID: 4109467
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of serum vitamin B 12 binding on intrinsic factor antibody detection in pernicious anaemia.
    Ghazi HA
    Acta Haematol; 1972; 47(5):264-8. PubMed ID: 4625456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of serum vitamin B12 in hematologic diseases].
    Anger G; Senf L; Schmidt U; Mattheus A
    Z Gesamte Inn Med; 1979 Aug; 34(15):suppl 196-7. PubMed ID: 294003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the vitamin-B12 level in patients with pernicious anemia].
    Fischer H; Sorger D
    Z Arztl Fortbild (Jena); 1978 Mar; 72(5):233-5. PubMed ID: 654331
    [No Abstract]   [Full Text] [Related]  

  • 7. [An antibody against a vitamin B 12-binding serum protein (transcobalamin II). A cause of a high content of vitamin B 12 in the serum of patients treated with delayed-action B 12 preparations].
    Schwartz M; Hom B; Olesen H; Bastrup-Madsen P
    Ugeskr Laeger; 1968 May; 130(20):862-6. PubMed ID: 5723667
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum-vitamin B12 during maintenance therapy in pernicious anemia with a depot preparation of vitamin B12.
    Bastrup-Madsen P; Schwartz M; Norregaard S; Hansen T; Meulengracht E
    Lancet; 1966 Apr; 1(7440):739-41. PubMed ID: 4159722
    [No Abstract]   [Full Text] [Related]  

  • 9. Coexistence of pernicious anaemia and chronic myeloid leukaemia: an experiment of nature involving vitamin B12 metabolism.
    Corcino JJ; Zalusky R; Greenberg M; Herbert V
    Br J Haematol; 1971 May; 20(5):511-20. PubMed ID: 4103047
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody to transcobalamin II and B12 binding capacity in patients treated with hydroxocobalamin.
    Skouby AP; Hippe E; Olesen H
    Blood; 1971 Dec; 38(6):769-74. PubMed ID: 5126165
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoration of decreased suppressor cells by vitamin B12 therapy in a patient with pernicious anemia.
    Kubota K; Arai T; Tamura J; Shirakura T; Morita T
    Am J Hematol; 1987 Feb; 24(2):221-3. PubMed ID: 2949604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of long-term oral vitamin B12 therapy to replenish body B12 stores.
    Brody EA
    Am J Clin Nutr; 1967 May; 20(5):443-5. PubMed ID: 6067224
    [No Abstract]   [Full Text] [Related]  

  • 13. The disappearance of intravenously administered vitamin B12. Studies in normal subjects and in patients with pernicious anemia.
    Estren S; Brody EA; Wasserman LR
    Am J Clin Nutr; 1960; 8():259-64. PubMed ID: 13820886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gamma-D-paraproteinemia. Clinical case contribution based on 2 studies].
    Spengler GA; Bütler R; Pflugshaupt R; Lopez V; Barandun S
    Schweiz Med Wochenschr; 1967 Feb; 97(6):170-8. PubMed ID: 4175061
    [No Abstract]   [Full Text] [Related]  

  • 15. A procedure for detaching bound vitamin B12 from its transport proteins.
    Gräsbeck R; Stenman UH; Puutula L; Visuri K
    Biochim Biophys Acta; 1968 May; 158(2):292-5. PubMed ID: 4968887
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum vitamin B level in long-term treatment of pernicious anemia with depot vitamin B 12 (Betolvex)].
    Bastrup-Madsen P; Norregaard S; Schwartz M; Hansen T; Meulengracht E
    Ugeskr Laeger; 1966 Mar; 128(9):261-4. PubMed ID: 5915744
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment with mecobalamin in a pernicious anemia patient presenting with false-normal serum vitamin B12].
    Shishido T; Hiroshima Y; Uematsu N; Kazumoto H; Kaiume H; Kirihara T; Takeda W; Ueki T; Sumi M; Kobayashi H
    Rinsho Ketsueki; 2018; 59(6):675-681. PubMed ID: 29973442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against intrinsic factor in oral treatment of pernicious anemia with highly purified hog intrinsic factor-vitamin B 12 complex].
    Neumann E; Honetz N
    Blut; 1972 Jan; 24(1):6-11. PubMed ID: 5062025
    [No Abstract]   [Full Text] [Related]  

  • 19. Recognition and resolution of errors in the radioisotopic assay of serum vitamin B12.
    Frenkel EP; McCall MS; White JD
    Am J Clin Pathol; 1970 Jun; 53(6):891-903. PubMed ID: 5504608
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison between the durations of the effects of the vitamin B12 preparations Betolvex and Vibeden].
    Bastrup-Madsen P
    Ugeskr Laeger; 1973 Sep; 135(38):2037-41. PubMed ID: 4774011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.